The emphasis in clinical cancer trials on using combination therapies to shut down the EGFR pathway prompts Dr. John Marshall to ask whether this approach represents progress or a return to a failed past. Medscape Hematology-Oncology
Tumor-associated macrophages, which play a key role in the pathogenesis of high-grade breast cancers, could serve as prognostic markers and potential therapeutic targets. Expert Review of Molecular Diagnostics
When 10 recently identified SNPs associated with breast cancer were added to a commonly used risk-assessment tool, performance only moderately improved. Medscape Medical News
Ten-year survival rates are high when patients with unfavorable localized prostate cancer are treated with external beam radiotherapy boosted with conformal high-dose-rate brachytherapy. Reuters Health Information
